PULVIRENTI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.266
EU - Europa 404
AS - Asia 272
SA - Sud America 11
AF - Africa 4
Totale 1.957
Nazione #
US - Stati Uniti d'America 1.253
IT - Italia 217
SG - Singapore 138
IN - India 63
SE - Svezia 57
CN - Cina 51
BG - Bulgaria 26
UA - Ucraina 20
DE - Germania 19
FI - Finlandia 19
ID - Indonesia 14
CA - Canada 12
GB - Regno Unito 9
NL - Olanda 8
RO - Romania 8
AR - Argentina 5
BR - Brasile 5
IE - Irlanda 5
ES - Italia 3
FR - Francia 3
TG - Togo 3
TW - Taiwan 3
BE - Belgio 2
DK - Danimarca 2
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
TR - Turchia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.957
Città #
Fairfield 230
Singapore 109
Ashburn 103
Seattle 89
Woodbridge 88
Chandler 86
Houston 77
Cambridge 74
Rome 66
Wilmington 57
Santa Clara 40
Princeton 32
Ann Arbor 26
Sofia 26
San Paolo di Civitate 24
Beijing 22
Dearborn 22
Lawrence 21
Boston 20
Plano 20
San Diego 18
Milan 15
Jakarta 14
Millbury 13
Jacksonville 7
Norwalk 7
Pescara 7
Toronto 7
New York 6
Turin 6
Dublin 5
Helsinki 5
Munich 5
Ottawa 5
Rio de Janeiro 5
Andover 4
Buffalo 4
Ostra Vetere 4
Phoenix 4
Belgioioso 3
Buenos Aires 3
Campobasso 3
Cassano Magnago 3
Hefei 3
Jamaica Plain 3
Lomé 3
London 3
Nanchang 3
Pomezia 3
Rimini 3
Taipei 3
Ahmedabad 2
Ancona 2
Bari 2
Bellevue 2
Brussels 2
Bühl 2
Casoria 2
Cesena 2
Civitanova Marche 2
Des Moines 2
Falls Church 2
Federal 2
Florence 2
Forlì 2
Frankfurt am Main 2
Genova 2
Hyderabad 2
Nanjing 2
Napoli 2
Nuremberg 2
Padova 2
Redwood City 2
Shanghai 2
Stockton-on-Tees 2
Tivoli 2
Trento 2
Amsterdam 1
Avellino 1
Bengaluru 1
Bern 1
Bhopal 1
Boardman 1
Bremen 1
Brno 1
Chicago 1
Chongqing 1
Dallas 1
Falkenstein 1
Fremont 1
Gunzenhausen 1
Hebei 1
Hounslow 1
Istanbul 1
Jinan 1
Lappeenranta 1
Los Angeles 1
Manila 1
Mannheim 1
Marano di Napoli 1
Totale 1.484
Nome #
Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire. 115
Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment 108
Differential diagnosis in hypogammaglobulinemia 104
Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies 89
Double-Blind, Placebo-Controlled Randomized Trial on Low Dose Azithromycin Prophilaxis in Primary Antibody Deficiencies 85
Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency 78
Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies 74
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 74
Adequate Patient's Outcome Achieved with Short Immunoglobulin Replacement Intervals in Severe Antibody Deficiencies 73
Human herpesvirus-8–positive primary effusion lymphoma in HIV-negative patients: single institution case series with a multidisciplinary characterization 71
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. 69
null 68
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 68
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study 66
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 59
null 52
null 51
Serum free light chains in common variable immunodeficiency disorders: role in differential diagnosis and association with clinical phenotype 49
null 46
null 44
Clinical use of polyvalent immunoglobulins 43
The olfactory function in patients with common variable immunodeficiency 43
Neuroinflammation and oxidative stress in individuals affected by DiGeorge syndrome 39
Covid-19, anosmia, and allergies. is there a relationship? a pediatric perspective 37
Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer–BioNTech Vaccine in Children Aged 5–11 Years: An Italian Real-World Study 35
Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID 33
Pulmonary diseases in primary immunodeficiency syndromes 33
Clinical Risk Factors for Aortic Root Dilation in Patients with 22q11.2 Deletion Syndrome: A Longitudinal Single-Center Study 31
Graft versus host disease 31
Pulmonary disease in primary immunodeficiency syndromes 30
Polyvalent immunoglobulins: challenges and perspectives. 28
IGA antibody induced by immunization with pneumococcal polysaccharides is a prognostic tool in common variable immune deficiencies 28
Coexisting genetic findings in a cohort of patients with laboratory confirmation of 22q11.2 deletion syndrome 24
Tailored therapies for primary immunodeficiencies 24
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters 23
Evaluation of the Benefit/Cost/Safety Profile of Low-dose Anti-CD20 Monoclonal Antibody (Rituximab) Treatment for Refractory Mixed Cryoglobulinemia 23
Magnetic resonance with diffusion weighted imaging: A new method to detect active lung inflammation in patients with primary antibody deficiencies 22
Case report. interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2. are all heterozygous born equals 20
Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies 14
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022 11
Health-Related Quality of Life and Patients' Empowerment in the Health Care of Primary Immune Deficiencies 11
Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies. 9
Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome 8
Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency 7
Hyper-IgE in the allergy clinic––when is it primary immunodeficiency? 7
Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-analysis 7
Efficacy and safety of clozapine in treatment-resistant psychotic patients with DiGeorge syndrome (22q11.2 deletion syndrome): a case series 4
Group A Streptococcus infections in children and adolescents in the post-COVID-19 era: a regional Italian survey 4
Antibody-dependent Natural Killer (NK) cell activation and functions after recombinant Herpes Zoster (HZ) Vaccine in immunodeficient patients 3
null 3
Totale 2.078
Categoria #
all - tutte 7.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020268 0 0 0 0 0 54 53 37 55 25 23 21
2020/2021199 24 20 19 14 2 23 8 15 24 27 16 7
2021/2022298 15 12 20 6 42 7 7 25 28 31 49 56
2022/2023334 57 68 15 22 52 33 7 18 35 4 10 13
2023/2024286 13 35 26 25 24 50 5 21 7 38 24 18
2024/2025266 23 44 42 59 65 33 0 0 0 0 0 0
Totale 2.078